Abstract. Bone marrow-derived mesenchymal stem cells (BMSCs) and adipose tissue-derived mesenchymal stem cells (ADSCs) are able to differentiate into neuron-like cells when exposed to small molecule compounds, however the specific differences in their neuronal differentiation abilities remain to be fully elucidated. The present study aimed to compare the neuronal differentiation abilities of BMSCs and ADSCs. BMSCs and ADSCs from the same Sprague Dawley rats were isolated and cultured for use. The proliferation capacity was revealed using a cell counting method. Following BMSCs and ADSCs induction by four types of small-molecular compounds, the expression of various neuronal markers and the secretion of several neurotrophic factors were detected by immunofluorescence, western blotting, reverse transcription-quantitative polymerase chain reaction and ELISA. It was demonstrated that the ADSCs exhibited an increased proliferation capacity compared with BMSCs, according to cumulative population doubling analyses. Following a 7-day neuronal induction period, BMSCs and ADSCs exhibited a neuron-like morphology, and were termed neuronal induced (NI)-BMSCs and NI-ADSCs. They expressed neuronal markers including β-tubulin III, microtubule associated protein 2 and choline acetyltransferase. The number of NI-BMSCs that positively expressed the neuronal markers was significantly decreased compared with NI-ADSCs, and the expression and secretion of the neurotrophic factors nerve growth factor and 3'-nucleotidase in NI-BMSCs were additionally decreased compared with NI-ADSCs. The findings of the present study indicated that the neuronal differentiation abilities and neurotrophic factor secretion abilities of ADSCs were increased compared with BMSCs. ADSCs may therefore act as efficient candidates in cell transplantation therapy for diseases and injuries of the nervous system.
Introduction
Treatment of nervous system diseases and injuries remains a clinical challenge, because neurons, terminally differentiated cells, can hardly regenerate once damaged. So seeking for suitable cells to replace damaged neurons has long been a hot research topic in cell therapy field (1, 2) . Mesenchymal stem cells (MSCs) have been generally considered a viable source for cell therapy due to their self-renewal and multiple differentiation capabilities, as well as their easy availability from various sources including the marrow, adipose tissue, cord blood and other adult tissues (3, 4) . As BMSCs can proliferate rapidly and differentiate into neuron-like cells under certain conditions, continuous attention has been paid to their potential application to the treatment of nerve injuries and degeneration (5, 6) . However, the differentiation potential, available quantity and the duration of BMSCs has been weakened with aging (7, 8) , while ADSCs are less affected by aging. In addition, an individual has abundant adipose tissues separated easily without causing significant injuries (9, 10) . Given the same mass, more cells could be obtained from the adipose tissue than those from the bone marrow (11) . ADSCs differ insignificantly from BMSCs in morphology and phenotypic characteristics (12, 13) , but their differences in neuronal differentiation ability under the same circumstance remain unknown and need to be further explored.
Knowing that BMSCs can promote functional recovery and protect neurons by secreting neurotrophic factors in nervous system (6) , the ability of BMSCs in secreting neurotrophic factors in vitro can reflect their therapeutic ability in vivo to some extent. The aim of the present study was to investigate whether ADSCs and BMSCs have the same ability to secrete neurotrophic factors, and whether these neurotrophic factors undergo any significant changes during neuronal induction.
Comparison of the neuronal differentiation abilities of bone marrow-derived and adipose tissue-derived mesenchymal stem cells
There are controversies over the selection of the neuronal differentiation methods. For instance, neuron-like cells induced by some methods only expressed immature rather than mature neuronal markers (5, 11, 14, 15) . In addition, some studies (12, (16) (17) (18) reported that induced cells differed greatly from neuronsin morphology and no electrophysiological characteristics of neurons. However, cells induced by our group method, showed neuron-like morphology and expressed mature neuronal marker MAP2 (19, 20) . In addition, it exhibited electrophysiological characteristics of neurons and expressed the sodium and potassium channels. When they were transplanted into the injured sciatic nerves of the rats, there presented an obvious effect on recovering the nerve function.
Currently, cell proliferation ability, differentiation ability into neuron-like cells, expression and secretion of neurotrophic factors in BMSCs and ADSCs have been compared in the present study. Isolation and culture of BMSCs. Bone marrow was harvested from the bilateral femurs and tibias by cutting off both ends. The marrow cavity was flushed with 10 ml Dulbecco's modified Eagle's medium/nutrient mixture F-12 (DMEM/F12, Gibco, Grand Island, NY, USA). The flushing fluid was collected and centrifuged at 230 x g (Becman Allegra X-12 Centrifuge, Becman Coulter, Inc., Brea, CA, USA). Cells were placed in a 25-cm 2 flask at a concentration of 2x10 4 cells/cm 2 in a Growth Medium for SD rat BMSCs (Cyagen, Guangzhou, China), and then incubated in the humidified atmosphere with 5% CO 2 at 37˚C. After 24 h incubation, the medium was replaced, and nonadherent cells were removed. Cells of passages 2-4 were used for all experiments. Neuronal induction. Neuronal induction was performed by the method described before (20) . Briefly, an appropriate amount of passage 4 BMSCs and ADSCs were digested by digestive enzyme (Tryple Express, Gibco) and plated at 8.5x10
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Animals
3 cells/cm 2 in 6-well plates or 24-well plates coated by poly-L-ornithine/laminin (Gibco, USA). Then neuronal induction medium, consisting of DMEM/F12, 0.5% FBS, 1% penicillin/streptomycin (Gibco), 1% glutamin, 1% N2, 20 ng/ml basic fibroblast growth factor (bFGF; all Gibco), 200 nM trichostatin A (TSA, histone deacetylases inhibitor; Sigma), 10 µM RG-108 (DNA methyltransferase inhibitor, Santa Cruz, USA), 10 µM 8-BrcAMP (highly stable, biologically active form of cAMP; Sigma) and 1 µM Rolipram (phosphodiesterases inhibitor; Sigma) was added. Half of the medium was replaced every other day. Related markers of neuronal differentiation were detected at day 1, 3 and 7.
Immunofluorescence. Cells in the 24-well plate were fixed by acetone at 4˚C for 10 min, flushed with PBS for three times, permeabilized with 0.3% Triton X-100 for 10 min, and blocked with 10% goat serum (Google, Wuhan, China) for 30 min. The primary antibody was diluted with 0.3% Triton X-100 and stayed overnight at 4˚C. The primary antibodies are mouse anti-β-tubulin III (1:400), mouse anti-MAP2 (1:400) and mouse anti-ChAT (1:200; all Abcam). The second antibody (goat anti-mouse, 1:400 Dylight, Invitrogen, CA, USA) was hatched at room temperature for 1 h. DAPI (Google) was counterstained for 5 min. Immunofluorescence staining was observed under a fluorescence microscope (Leica Microsystems GmbH, Wetzlar, Germany).
Quantitative real-time PCR (qRT-PCR). Both BMSCs and
ADSCs were divided into four groups: native group, and 1-, 3-and 7-day neuronal induction groups. TRIzol was used to extract total RNA. The concentration and purification of cells were detected by using a nucleic acid detector (Nanodrop-2000, Thermo Fisher Scientific, Wilmington, DE, USA, USA). Reverse transcription and PCR amplification were performed as per instructions on the kit. The primers were designed and synthesized by Google Biological Company (Wuhan, China (Table I ). The primers sequences were listed in Table I . β-actin was used as an endogenous control to normalize gene expression levels. The reverse transcription conditions are as follows: 37˚C 15 min, 85˚C 5 sec, thermal insulation at 4˚C, and the PCR amplification conditions are as follows: 5˚C 3 min, 95˚C 10 sec, 58.5˚C 30 sec, 72˚C 40 sec, 40 cycles. Analysis of relative gene expression data was usingthe 2 -ΔΔCt method (21) .
Western blot analysis. BMSCs and ADSCs in the 6-well plate were flushed with 0.1M PBS, lysed by addition of radio-immunoprecipitation assay (RIPA) buffer (Google), and centrifuged at 4˚C to harvest the supernatant and detected the protein concentration by Bradford method. Then, the supernatant was boiled at 100˚C and centrifuged for later use. After preparation of the separation gel and addition of the sample, sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed. An equal amount (10 mg) of protein extracted from these samples was resolved on a 4-15% polyacrylamide gradient. Then the protein was transferred to the nitrocellulose membrane. The membrane was blocked in 5% skimmed milk/PBS for 1 h and then incubated with primary antibodies nestin (rabbit anti-rat monoclonal antibody, 1:2,000), β-tubulin III (rabbit anti-rat monoclonal antibody, 1:1,000), MAP2 (rabbit anti-rat monoclonal antibody, 1:2,000), synaptophysin (rabbit anti-rat monoclonal antibody, 1:2,000), NGF (rabbit anti-rat monoclonal antibody, 1:2,000), NT-3 (rabbit anti-rat monoclonal antibody, 1:1,000), brain derived neurotrophic factor (BDNF, rabbit anti-rat monoclonal antibody, 1:2,000; all Abcam) and GAPDH (rabbit anti-rat monoclonal antibody, 1:2,000; Wei'ao, Shanghai, China). After incubation with horseradish peroxidase (HRP)-marked goat anti-rabbit second antibody (1:2,000, Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA), chemiluminescence was detected by exposure to X-rays. The bands were quantified using Odyssey v1.2 software (LI-COR Biosciences, Lincoln, NE, USA) by measuring the band intensity for each group and normalizing to GAPDH as an internal control. The western blot experiment was repeated at least three times. ELISA. Enzyme-linked immunosorbent assay (ELISA) kit (Wei'ao) was used to measure the level of NGF, NT-3, BDNF in culture medium according to the manufacturer's instruction. Passage 4 BMSCs and ADSCs were resuspended and plated into 6-well culture plates at a concentration of 5x10 5 cells/well, and induced by the medium used above. Then DMEM/F12 was replaced by serum-free medium. After 48 h induction, the supernatant was collected and used for the measurement of NGF, NT-3, BDNF level secreted by BMSCs and ADSCs.
Statistical analysis. All the above tests were performed at least in triplicate. The results were analyzed by using the statistical software SPSS 21.0 (IBM SPSS, Armonk, NY, USA The data were expressed as Standard Deviation (SD). The quantitative figures in this work represent the mean ± standard error of mean (SEM). Repeated measure Analysis of Variance (ANOVA) was used for statistical analysis. Values of P<0.05 were considered statistically significant.
Results
Morphology and phenotypic characteristics of BMSCs and
ADSCs. Both BMSCs and ADSCs were long spindle-shaped with oval-shaped nuclei, growing homogeneously. Compared with ADSCs, BMSCs were thinner and longer. Neither BMSCs nor ADSCs underwent significant morphologic change from the primary generation to the fourth generation (Fig. 1A-D) .
To further explore the phenotypic characteristics of BMSCs and ADSCs, immunophenotypic analysis was performed by flow cytometry method. It was found that both BMSCs and ADSCs expressed CD44 and CD90 (>99%), but neither CD34 nor CD45, indicating that both BMSCs and ADSCs expressed typical surface markers of MSCs. In addition, the purity of both mesenchymal stem cells were relatively high (Fig. 2) .
Cell proliferation ability. Knowing that harvest of large amounts of cells within a short period is of great clinical significance in cell therapy, the cell proliferation ability Fig. 3) . The results suggested that ADSCs proliferated more quickly than BMSCs in vitro. 
Morphological changes of BMSCs and ADSCs after neuronal induction.
Morphological changes were observed in BMSCs at day 4 after neuronal induction. It was found the cellular bodies became round or oval gradually, and the processes became thinner and longer. These changes were observed in ADSCs at day 3 after neuronal induction, indicating that morphologic changes occurred earlier in ADSCs than those in BMSCs. At day 7 after neuronal induction, both NI-BMSCs and NI-ADSCs exhibited a neuronal morphology (Fig. 4A-D) . In NI-BMSCs, the cellular bodies were looked round or oval, much bigger in size and with 3-5 long processes, while they were round, much smaller in size and with 2-3 short processes in NI-ADSCs. The induction rate were (73.61±3.43) and (93.01±2.65)% for BMSCs and ADSCs, respectively (P<0.05). These changes suggested that both BMSCs and ADSCs were able to differentiate into neuron-like cells in morphology. In comparison, ADSCs differentiation was faster and induction rate was higher.
Expression of neuronal markers in BMSCs and ADSCs.
Immunocytochemistry was used to characterize ADSCs and BMSCs (Fig. 5) . It was found that the positive cells for β-tubulin III of BMSCs (Fig. 5A) were (12.5±1.80)%, which were lower than (19.5±1.50)% of ADSCs (P<0.05; Fig. 5D) . No MAP2 or ChAT positive cells was exhibited in BMSCs ( Fig. 5B and C) and ADSCs ( Fig. 5E and F) (Fig. 5G-L) . After neuronal induction, the neuronal marker expression was increased significantly in both NI-BMSCs and NI-ADSCs. The expression of β-tubulin III and ChAT in NI-BMSCs were significantly lower than that in NI-ADSCs, while the expression of MAP2 in BMSCs was higher than that in ADSCs.
The expressions of neuronal marker genes at transcriptional level of BMSCs and ADSCs were detected by qRT-PCR. Expressions of these genes of both cells increased significantly after neuronal induction. Expression of nestin mRNA (Fig. 6A) began to increase after 1-day induction, and remained unchanged significantly after 1-, 3-and 7-day induction, While mRNA expression of β-tubulin III, MAP2 and ChAT (Fig. 6B-D) began to increase after 1-day induction, and reached the peaks at day 7. Compared with BMSCs, the mRNA expression of nestin, β-tubulin III and ChAT in ADSCs were relatively higher both before and after induction, while the mRNA expression of MAP2 mRNA was lower than that in BMSCs.
The results of western blot were consistent with the immunofluorescence and qRT-PCR. After 7-day neuronal induction, the protein expression of nestin, β-tubulin III, MAP2 and synaptophysin (Fig. 7A-E ) was higher than that of native BMSCs and ADSCs. The protein expression of β-tubulin III and synaptophysin protein in ADSCs was higher than that in BMSCs both before and after neuronal induction, while the protein expression of MAP2 in ADSCs was lower than that in BMSCs. There was no difference between BMSCs and ADSCs in protein expression of nestin.
Expression and secretion of neurotrophic factors.
The results of qRT-PCR showed that both BMSCs and ADSCs expressed constitutive gene of neurotrophic factors such as NGF, NT-3 and BDNF at transcriptional levels. After neuronal induction, the NGF, NT-3 and BDNF increased with culture time and reached the peak at day 7. There was higher expression of BDNF, but lower expression of NGF and NT-3 in BMSCs compared with ADSCs ( Fig. 8A-C) . We also detected the neurotrophin glial cell derived neurotrophic factor (GDNF) and found that there was no significant difference between native and neuronal induced BMSCs and ADSCs.
We qualified the protein expression of neurotrophic factors by western blot (Fig. 9A) . The results confirmed that native BMSCs and ADSCs had also expressed NGF, NT-3 and BDNF (Fig. 9B-D) . After neuronal induction, the expression of NT-3 in NI-ADSCs was increased compared with that in NI-BMSCs, whereas the change of NGF had no statistical significance. However, NI-BMSCs and NI-ADSCs expressed less BDNF than native ones. The protein expression of NGF and NT-3 in NI-ADSCs were greater than those in NI-BMSCs, while the protein expression of BDNF had no statistical significance between NI-BMSCs and NI-ADSCs. Secretions of neurotrophic factor in BMSCs and ADSCs. The secretions of neurotrophic factor in BMSCs and ADSCs were measured by ELISA. It was found that both NI-BMSCs and NI-ADSCs secreted more NGF, NT-3 and BDNF compared with the native ones (Table II, Fig. 10 ). Compared with ADSCs, native and NI-BMSCs secreted more BDNF, but less NGF and NT-3.
Discussion
ADSCs have advantage in harvest. MSCs can be easily obtained from the bone marrow and adipose tissues, but more easily from subcutaneous adipose tissues, which is more acceptable for the patients. In our study, 8x10 4 adherent BMSCs could be obtained from the bone marrow of bilateral tibias and femurs in a 45 g SD rat after 24 h incubation, and increased to 7-8x10 5 cells after one-week culture, while 1x10 5 adherent ADSCs were harvested from inguinal adipose tissues in the same rat, then increased to 7-9x10 6 after one-week culture. Compared with BMSCs, more ADSCs could be easily harvested from the same donor, and ADSCs also proliferated more rapidly than BMSCs at same condition. The quantity and activity of the BMSCs reduced apparently with aging, while ADSCs were less affected, suggesting that ADSCs are a more effective source for clinical use.
Neuronal differentiation ability. BMSCs and ADSCs are known to differentiate into neurons (22, 23) . In our study, nestin, a neural precursor stem cells marker, and β-tubulin III, an immature neuronal marker, were expressed in native BMSCs and ADSCs, which suggested that both MSCs retained a native potential for neuronal differentiation and were in conformity with other studies (20) . After 7-day neuronal induction, the expression of β-tubulin III, ChAT and synaptophysin in ADSCs was significantly higher than that in BMSCs, indicating that ADSCs had a higher ability of neuronal differentiation than BMSCs. The reason may be that MSCs are composed of more than one type of precursor cells. As the proportion of different precursor cells is different in BMSCs and ADSCs, their adipogenic, osteogenic and neurogenic abilities are different (24) .
Ability of secreting neurotrophic factors of induced cells.
Neurotrophic factors such as NGF, NT-3, BDNF are known as neuron growth nutrients, which play an important role in neuroblast proliferation, maturation and phenotype maintenance (25) (26) (27) (28) . To explore whether the NI-BMSCs and NI-ADSCs had neuronal functions, we detected the expression and secretion of neurotrophic factors. It was found that NGF, NT-3 and BDNF mRNA expressions in both BMSCs and ADSCs increased in varying degrees after neuronal induction. But surprisingly, protein expression of NGF, NT-3 had insignificantly changed and BDNF decreased to some extent. The mechanism of this phenomenon is unknown. qRT-PCR detects the mRNA of genes at transcriptional level, while western blot and ELISA are at protein level. Expression of neurotrophins, such as NGF, BDNF, NT-3, not only are regulated at the transcriptional level, also are post-translationally modificated by elaborated intracellular systems (29) . They are synthesized as inactive precursor proteins, pro-neurotrophins, and then are processed into active molecules via multipe steps involving glycosylation, sorting, proteolytic cleavage and secretion (30) . For example, after synthesis of BDNF mRNA, BDNF protein is initially produced as a precursor protein (proBDNF), followed by post-translational cleavage of proBDNF into the mature form of BDNF by intracellular and/or extracellular proteases (31) . Another interesting finding was reported that the mRNA levels of NGF and BDNF in both ADSCs and BMSCs improved rapidly but their protein levels decreased during the course of neural differentiation which was attributed to neurotrophins might be consumed during the course of neural differentiation (17) . So there may exist some differe nces between different levels.
Both BMSCs and ADSCs secreted more NGF, NT-3 and BDNF after neuronal induction. The native and NI-ADSCs secreted more NGF and NT-3, but less BDNF than BMSCs, suggesting that the two types of MSCs may express different neurotrophic factors.
Based on the results of this comparative study, we draw the following conclusions: (i) There are insignificant differences in morphologic and phenotypic characteristics between BMSCs and ADSCs derived from the same SD rats, except that cell bodies of BMSCs are larger than those of ADSCs.
(ii) Compared with BMSCs, ADSCs proliferate significantly faster. (iii) BMSCs and ADSCs can be easily induced into neuron-like cells by using the four small-molecular compounds. (iv) The expression of neuronal marker β-tubulin III, ChAT and synaptophysin in ADSCs are higher than those in BMSCs, suggesting that ADSCs have stronger capability of differentiation into neuron-like cells. (5) The expression and secretion of neurotrophic factors NGF and NT-3 in ADSCs are higher than those both in native and NI-BMSCs, suggesting that ADSCs have a better trophic effect in neuronal replacement therapy.
In summary, ADSCs differs insignificantly from BMSCs in morphology and phenotypic characteristics. However, ADSCs proliferate significantly faster, differentiate into neuron-like cells faster, and express higher levels of NGF and NT-3. ADSCs may have more potential than BMSCs in the treatment of nervous systems diseases.
